ahs13 jeff leighton — the role of omega 3 oils in the treatment of chronic inflammation (ahs13)

14
Omega 3 Oil Optimization Study Dr Jeff Leighton, Chief Science Officer and Vanessa Whiting, Senior Nutritionist

Upload: ancestral-health-society

Post on 20-May-2015

856 views

Category:

Health & Medicine


3 download

DESCRIPTION

Inflammation is associated with virtually all chronic, progressive diseases such as heart disease, vascular disease, asthma, IBS, autoimmune diseases, rheumatoid arthritis, osteoarthritis and even chronic neurological diseases such as Alzheimer’s disease. The signals that induce inflammation are multifactorial. High dose omega 3 has the potential to be as or more effective than pharmaceutical therapies. We will report on a series of omega 3 studies that compared dose response, dose timing, (e.g. once a day or twice a day), and food intake (with or without) in four separate cohorts.

TRANSCRIPT

Page 1: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

Omega 3 OilOptimization Study

Dr Jeff Leighton, Chief Science Officerand

Vanessa Whiting, Senior Nutritionist

Page 2: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

DOSE-RESPONSE CONSIDERATIONS# of Health Benefits

DOSEVariables: • Exercise

• BMI• Diet• Chronic Disease• Age• Gender

CV.…………………….2-3 gramsTGs…………………….4 gramsInflammation………..> 4 gramsCNS……………………?Women’s Health…….?G.I. (Leaky Gut)……..?

Page 3: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

# of Health Benefits

Max

3 6 9 12 15

?

% Omega 3 Incorporation

• We need to correlate % omega 3 incorporation with health benefit

• Assuming the use of a highly potent omega 3 oil and an optimized formulation and dosing regimen, what is the practical upper limit to omega 3 oil incorporation?

Page 4: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

PROCESS• Abstain from all Omega 3 supplements for 30 days

• Measure Omega 3 (baseline)

• Dose for 30 days

• Food and exercise survey filled out on a daily basis allowing verification of diet, exercise and pain

• Measure Omega 3

• In a subset group, measured rate of loss of Omega 3 (7 day and 30 day)

Study involved 136 volunteersVolunteers were recruited largely from the

Northeast region

Page 5: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

METHODS

Omega 3 Index Assay • Developed by Dr. Bill Harris

• CLEA Approved finger prick assay• Detects % of Omega 3 fats in RBC membranes

SFH Omega 3 Oil• IFOS certified• CRN, GOED compliant• Dose strength per 5 ml (1 teaspoon)• EPA 2235mg• DHA 990mg • Total 3225mg/ 5 ml• Ratio Omega 3: Omega 6 37:1

• Fatty acids are in triglyceride form

Page 6: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

QUESTIONS ADDRESSED1. What is the best dosing paradigm to optimize Omega 3 fat

incorporation?• Once a day?• Twice a day?• With food?• 1 tsp vs 2 tsp of SFH Omega 3 oil?

2. Does BMI, gender, age, exercise or chronic disease affect Omega 3 fat incorporation?

3. What is the rate of loss of Omega 3 fats following a steady state dosing period?

Page 7: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

100

25

-25

-50

50

75

Basal

14.6/ 5.35

34.9/ 6.30

17.5/ 5.49

79/ 8.36

122/ 10.38

220/ 15.04

Ave 4.67%Athletes

Fish 1x week, no omega 3 oilNo fish and no fish oil

1 tps fish oil, no food

2 tps fish oil, no food

2 tps fish oil BID2 tps fish oil with food once a day

42% 20%

No nuts, low carb, red meat ≤ 3x/ week

Dose Optimization summary

99/ 9.29

121/ 10.32

Page 8: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

BMI Diet Number Baseline % Stimulated %

18-25 Stand. American

13 4.78 9.55

Low Carb 16 5.52 9.60

25-30 Stand. American

13 4.56 8.87

Low Carb 17 5.01 8.34

>30 Stand. American

8 5.23 8.32

Low Carb 4 4.50 8.17

EFFECTS OF DIET ON OMEGA 3 INCORPORATION

Conclusion: the combination of low carb and low BMI translates into greater basal and stimulated omega 3

Page 9: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

Effect of Diagnosed Inflammation*

On Omega 3 IncorporationBMI Number Inflammation?

Baseline %

Stimulated %

18-25 9 Yes 5.78 9.15

21 No 5.20 9.70

25-30 9 Yes 5.05 8.78

22 No 4.68 8.38

>30 5 Yes 4.72 8.60

7 No 4.75 8.61

* Inflammation does not affect Omega 3 incorporation. As in other studies, individuals with BMI >25 have lower baseline and stimulated Omega 3 incorporation

Page 10: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

Number Baseline % Stimulated %

ALL 73 4.93 8.95

Males 25 4.30 7.64

Females 48 5.04 9.07

EFFECTS of GENDER ON

OMEGA 3 INCORPORATION

Conclusion: Females have higher baseline and aremore efficient incorporating Omega 3 Oil

Page 11: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

BMI Number Baseline % Stimulated %

18-25

ALL 32 5.18 9.58

Males 5 5.12 9.80

Females 27 5.20 9.54

25-30

ALL 30 4.94 8.61

Males 17 4.98 8.52

Females 13 4.90 8.72

>30

ALL 12 4.57 8.60

Male 3 4.36 7.83

Female 9 4.64 8.86

EFFECTS of BMI and GENDER ON

OMEGA 3 INCORPORATION

Conclusion: Effects of BMI on Omega 3 incorporation are modest but ahealthy BMI shows higher baseline and higher incorporation efficiency

Page 12: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

Effect of pre/ post menopausal and

BMI on Omega 3 incorporation

BMI Number Pre Post Baseline %

Stimulated %

18-25 22 5.27 9.43

3 4.46 9.90

25-30 10 5.18 8.39

4 4.27 8.70

>30 5 4.07 8.24

4 5.07 9.65

Estrogen state has little effect on omega 3 oil incorporation (preliminary conclusion). Larger study group required.

Page 13: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

% Change from baseline

50

80

100

X

30

X

9.71%X

7.36%

5.61%

Steady State

10 20

N=10, all athletes, athlete baseline 5.41%T ½ for Omega 3 loss approximately 7 days

Rate of loss of omega 3

incorporation

0Days

Page 14: AHS13 Jeff Leighton — The Role of Omega 3 Oils in the Treatment of Chronic Inflammation (AHS13)

Conclusion1. Individuals with a healthy BMI (18-25) have higher basal and stimulated omega 3

incorporation.

2. There is considerable dosing flexibility. A BID dose or once a day just

before or with food provides optimal omega 3 incorporation.

3. It is possible to increase omega 3 incorporation to approximately 15% with a low

carb/ low omega 6 diet (no nuts, with fish and red meat ≤ 3 days / week).

4. Individuals in generally good health, but not athletic have an average

omega 3 basal incorporation of 4.67%.

5. Athletes have a higher basal omega 3 incorporation of 5.35%

6. Age and diagnosed inflammation have no effect on omega 3 fat

incorporation.

7. Women have a higher basal and stimulated omega 3 oil incorporation.

8. Surprisingly, the t ½ for omega 3 loss is short (approximately 7 days)

despite being a lipid soluble fatty acid. The observation was from a

group of 10 athletes where exercise induced cell metabolism would be

expected to increase turnover of muscle

and energy stores.

9. With modest changes in diet, it is reasonable to achieve 9-10%

incorporation of omega 3 into cell membranesWhat are the maximum number of health benefits achieved with 10% omega 3 oil incorporation… TBD!